| Names | |
|---|---|
| Preferred IUPAC name | 4,5-Bis(hydroxymethyl)-2-methylpyridin-3-ol |
| Other names | Pyridoxine Pyridoxal Pyridoxamine PN PL PM Aderoxine Hexa-Betalin |
| Pronunciation | /ˌvaɪ.tə.mɪn ˈbiː sɪks ˌpɪr.ɪˈdɒk.siːn/ |
| Identifiers | |
| CAS Number | 65-23-6 |
| Beilstein Reference | 606922 |
| ChEBI | CHEBI:28965 |
| ChEMBL | CHEMBL409 |
| ChemSpider | 546 |
| DrugBank | DB00165 |
| ECHA InfoCard | 03bb875e-44ea-4e62-adaa-1957e6cfa996 |
| EC Number | EC 1.4.3.5 |
| Gmelin Reference | 83084 |
| KEGG | C00314 |
| MeSH | D014805 |
| PubChem CID | 1054 |
| RTECS number | TH9650008 |
| UNII | 68Y4CF58BV |
| UN number | UN2811 |
| CompTox Dashboard (EPA) | DTXSID9010402 |
| Properties | |
| Chemical formula | C8H11NO3 |
| Molar mass | 169.18 g/mol |
| Appearance | White or almost white crystalline powder |
| Odor | Odorless |
| Density | 0.9 g/cm³ |
| Solubility in water | Very soluble |
| log P | -0.64 |
| Acidity (pKa) | 8.6 |
| Basicity (pKb) | 8.57 |
| Magnetic susceptibility (χ) | -6.2·10⁻⁶ |
| Refractive index (nD) | 1.520 |
| Dipole moment | 2.71 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 143.6 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -382.3 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -3885 kJ/mol |
| Pharmacology | |
| ATC code | A11HA02 |
| Hazards | |
| Main hazards | May cause eye, skin, and respiratory irritation. |
| GHS labelling | Not classified as hazardous according to GHS |
| Pictograms | Vitamin, Immune, Nervous system, Energy |
| Signal word | No signal word |
| Precautionary statements | KEEP OUT OF REACH OF CHILDREN. If pregnant or breastfeeding, consult your healthcare professional before use. Do not exceed recommended dose. Store in a cool, dry place. Discontinue use and consult a physician if any adverse reactions occur. |
| Flash point | 79.6°C |
| Autoignition temperature | 300°C |
| Lethal dose or concentration | LD50 (rat, oral): 4 g/kg |
| LD50 (median dose) | 170 mg/kg (rat, oral) |
| PEL (Permissible) | 10 mg/m3 |
| REL (Recommended) | 1.4 mg |
| IDLH (Immediate danger) | No IDLH established |
| Related compounds | |
| Related compounds | Pyridoxal Pyridoxamine Pyridoxal phosphate Pyridoxamine phosphate 4-Pyridoxic acid |
| Item | Data | Technical Manufacturer Commentary |
|---|---|---|
| Product Name | Vitamin B6 | Commonly requested as Vitamin B6 for nutritional, pharmaceutical, and food fortification applications. Application requirements determine the final grade and micro-nutrient content. |
| IUPAC Name | 4,5-Bis(hydroxymethyl)-2-methylpyridin-3-ol | IUPAC nomenclature follows chemical identity standards for basic and technical grades, forming the basis for regulatory and customs documentation. |
| Chemical Formula | C8H11NO3 | The formula represents pure pyridoxine. Grade-specific formulation may involve excipients or hydration states; final delivered material composition adapts to end-use. |
| CAS Number | 65-23-6 | CAS registration applies to global sourcing and customs declarations. Manufacturers control for CAS-registered purity and avoid contaminants that could impact regulatory status. |
| Synonyms & Trade Names | Pyridoxine, Pyridoxol, Pyridoxine Hydrochloride (for salt), Antidermatitis Vitamin | Synonyms reflect both free base and salt forms. Form selection depends on processing stability and formulation compatibility, with hydrochloride preferred for many pharmaceutical and premix applications due to enhanced solubility and shelf stability. |
| HS Code & Customs Classification | 2936.29 | Customs classification follows international harmonized codes for vitamins and derivatives. Proper coding affects import/export duty and regulatory paperwork. Manufacturers allocate batch documentation for compliance with destination-specific customs entry. |
In commercial production of Vitamin B6, raw material selection emphasizes reactant purity to minimize organic and inorganic impurities. The synthetic route varies—direct amination or condensation chemistries may be implemented based on feedstock availability and plant infrastructure. Critical control points involve isolation and purification, as certain intermediates produce structurally related impurities cleared through crystallization, activated carbon treatment, and controlled recrystallization strategies.
Grade determination depends on both the active content and the content of related organic substances, chloride (for HCl salt), and heavy metals, which require continuous batch testing and calibration of process parameters. Differentiation between food and pharmaceutical grades relates to control levels for trace elements and residual solvents; regulatory requirements specify maximum impurity profiles, guiding in-process controls.
Batch-to-batch consistency gets managed by stringent process documentation and in-process monitoring—especially during final stage isolation and drying, where over-drying or unsuitable moisture content shifts free flowing properties and shelf life. Final release always considers both customer specification agreements and internal quality criteria, including assay, purity, particle size, solubility, and microbial limits.
Vitamin B6 exhibits hygroscopic characteristics depending on the crystalline form and level of hydration. Storage in sealed containers and desiccant use are standard practice to maintain assay accuracy until point of use. In finished premixes, compatibility tests determine the form selected, as certain excipients may promote degradation or color changes over time. Technical documentation includes stability data relevant to industrial packaging and typical warehouse conditions common in inbound and outbound logistics.
| Identifier | Value |
|---|---|
| CAS Number | 65-23-6 |
| Chemical Formula | C8H11NO3 |
| HS Code | 2936.29 |
| Main Synonyms | Pyridoxine, Pyridoxol, Pyridoxine Hydrochloride |
Vitamin B6 commonly appears as a crystalline or powdery solid. Color varies from white to off-white, depending on purity and grade. Most technical and pharmaceutical grades yield a powder with no detectable odor under typical plant room conditions. Melting point observations depend on grade; high purity will record a sharper melting transition. Excess moisture and residual solvent traces, if not controlled during drying, can cause caking or agglomeration in lower grades.
In industrial settings, the chemical stability of pyridoxine depends on environmental control throughout storage and production. Exposure to strong acids or oxidizers, as well as prolonged contact with UV light, leads to degradation. Heat buildup during milling or handling should be minimized to avoid thermal stress, which can promote discoloration and loss of potency.
Solubility in water varies by grade and polymorph. Fine-milled high-purity grades dissolve readily in neutral to mildly acidic aqueous media under agitation. Excess undissolved residue or incomplete dissolution signals either high impurity load or inappropriate solvent parameters. Technical teams adjust solution conditions based on downstream formulation requirements—pH control and filtration ensure clean, particulate-free stock solutions for use in formulations.
Specification targets depend on final application—nutritional, pharmaceutical, animal feed, or industrial intermediate. General parameters include content assay, moisture, residue on ignition, specific impurities, and particle size for flow and blending performance. Food and pharmaceutical grades require low heavy metal and organic impurity levels, with true specifications set between manufacturer’s internal controls and customer acceptance protocols.
Principal impurities arise from synthesis side reactions and raw material contaminants. These can include related pyridine derivatives, unreacted starting materials, and trace inorganic salts from neutralization steps. Impurity targets reflect regulatory and client standards. Routine trend analysis of each batch identifies any shifts in impurity distribution for timely corrective action.
Assay and purity measurements rely on methods such as HPLC, UV-Vis, and potentiometric titration, each protocol tailored to the material grade. Heavy metal screening follows pharmacopeia criteria when intended for direct human use, with periodic cross-validation against reference materials. For all non-pharma applications, test method selection prioritizes process consistency and practicality in high-volume QC environments.
The synthesis of pyridoxine typically starts from petrochemical or carbohydrate feedstocks, chosen for predictable supply and stable cost. Suppliers are audited for traceability, contaminant background, and batch consistency. Each incoming lot receives in-house verification before use in main reactions.
Industrial routes involve either catalytic hydrogenation of pyridoxine precursors or fermentation-based approaches. The chemical process often employs selective reduction and controlled crystallization to maximize yield and minimize side products. In both routes, careful pH adjustment and solvent management influence both speed and selectivity of critical steps; this directly impacts impurity carrythrough.
Multi-step filtration, recrystallization, and activated carbon treatment remove organic and inorganic by-products. Each purification phase includes in-line monitoring of critical quality attributes. Deviations in process pH, solvent quality, or temperature at these stages tend to show up in both yield loss and impurity spikes.
Final release decisions depend on combined in-process, intermediate, and finished goods analysis. Batch data are trended against historical norms. For regulated applications, full batch traceability and certificate of analysis are supplied, and ship-to-ship consistency is evaluated statistically before release.
Pyridoxine participates in reversible protonation and salt formation, and downstream functionalization at the methyl or hydroxymethyl position is well-documented for derivative manufacturing. Alkylation, acylation, and oxidation are commonly used in the preparation of analogs.
Reaction conditions for derivatization include use of acid or base catalysts, moderate heat, and organic solvents as dictated by the chemistry. Batch temperature stability remains critical; exothermic runaway or side reactions increase impurity risk.
Functional derivatives such as pyridoxal and pyridoxamine serve specialty nutrition and custom intermediates markets. Process adjustments for these materials focus on selective conversion and impurity minimization.
Temperature, humidity, and light exposure all influence pyridoxine shelf life. Facilities recommend stable, cool, and dry storage. Extended air exposure encourages gradual surface oxidation, with visible color change as an early sign. Light-resistant containers extend shelf life.
Glass, HDPE, and lined fiber drums resist powder–container interactions over long-term storage. Polybags and liners minimize dust and environmental ingress.
Product deterioration appears as yellowing, clumping, and assay drop. Shelf life is grade-specific, depending on moisture protection and post-packaging conditions. Any suspected degradation warrants batch retesting prior to dispatch.
Globally Harmonized System (GHS) classification and hazard statements align with the actual toxicity data and end-use profiles for each grade. Commercial pyridoxine is not considered acutely toxic by oral or dermal routes at standard concentration levels for industrial handling.
Environmental and occupational hygiene remains a top priority. Dust generation should be minimized—inhalation at high airborne concentrations may cause respiratory irritation. Standard antistatic, respiratory, and skin protection controls are employed in all powder handling zones.
Acute and chronic toxicity reflect grade and application exposure rather than single-exposure scenarios. Most occupational exposure studies place pyridoxine in a low-risk group, but workers receive routine training in dust containment and personal protective equipment practices. Documentation for regulated applications details observed and theoretical exposure limits.
In industrial production of Vitamin B6 (Pyridoxine), site capacity is influenced primarily by synthesis route selection, continuous batch throughput, and availability of qualified feedstocks such as 2-methyl-3-hydroxypyridine and intermediates. Multi-ton annual output is feasible at established facilities, but routine campaign planning must account for raw material procurement cycles, equipment maintenance, and energy reliability. Consistency in output aligns with the robustness of in-line process monitoring, purification efficiency, and parallel line redundancy—especially on USP, EP, and JP grades, where impurity thresholds require staged crystallization or filtration for each order.
Lead time varies by grade and requested packaging format. Orders calling for full-container-loads with non-standard pack sizes or customized labeling introduce delays related to final packing and batch release testing. Minimum order quantities (MOQs) align with batch size and equipment cleaning requirements; small lots for pharma or specialty use often aggregate to optimize line changeover efficiency. Large-scale orders for premix or food fortification grades may justify dedicated campaign runs.
Bulk Vitamin B6 leaves production sites in widely varying packages—multi-layer fiber drums with PE bag liners are standard for bulk export, as they address moisture sensitivity and prevent cross-contamination. Tailored packaging protocols support powder, crystalline forms, or microencapsulated derivatives. Higher pharmaceutical grades demand certified primary packaging suitable for direct tableting, sanitized under GMP protocols to meet regulatory expectations at point of use.
Shipping modalities depend on grade, client location, and downstream application. Ocean freight in temperature-stable containers dominates volume shipments, with air freight reserved for short shelf-life or urgent specialty batches. Payment terms are subject to client risk profile, industry norms, and contract history—prepayment, net 30, and letter of credit each see implementation across operating regions. Traceable lot release documentation must accompany every shipment, as major customers perform receiving QC audits before release to formulation.
Raw material costs account for the majority of ex-factory price volatility. Synthetic pyridoxine routes require 2-methyl-3-hydroxypyridine, activated chlorinating agents, and high-purity solvents. Market rates for these chemicals track refinery output, agricultural chemical demand, and regulatory shifts controlling hazardous precursor access. Price surges trace to disruptions in primary feedstock supply from China or India, regional environmental controls impacting chemical industrial parks, or force majeure from key intermediates plants.
Primary drivers for Vitamin B6 price instability come from:
Grade, purity, and packaging certification drive price stratification. Pharmaceutical grades cleared for cGMP-compliant use require extensive process validation, release testing, and impurity screening, raising production cost and batch rejection risk. Food and feed grades, while chemically similar, face lighter validation and allow broader specification tolerance. Packing in direct-use packaging for pharma or in child-resistant formats for OTC applications raises total delivered cost per kilogram compared to industrial bulk pack.
Global Vitamin B6 market volume distributes primarily through North America, Europe, China, India, and Japan, with China accounting for a dominant share of synthetic capacity. End-use splits across animal feed premixes, food fortification, and direct-use pharmaceutical APIs. Seasonal order peaks for premix and formulated tablets, plus regulation-driven inventory runs, cause short term demand surges.
| Economy | Demand Features | Supply Features |
|---|---|---|
| United States | Stringent FDA, cGMP for pharma, high nutraceuticals volume | Imports dominate; volumes set by US Pharmacopeia compliance |
| European Union | REACH, EFSA for food/feed, supply chain security focus | Import from Asia, local repack; periodic audits |
| Japan | JP Pharmacopoeia for pharma, niche supplement demand | High purity requirements, limited local manufacture |
| India | High-volume veterinary and food fortification | Domestic players plus Asian import blending |
| China | Bulk production, domestic and export both strong | Major global supplier, policy changes ripple overseas |
Looking ahead to 2026, pricing will reflect the net of Asia-Pacific capacity adjustments, input cost volatility, and regulatory strictness in anti-pollution and compliance regimes. Introduction of tightened emission norms for key intermediates in Jiangsu and Shandong, restructuring of regional production quotas and decarbonization incentives may elevate costs per kilo for all high-purity lots. End-use differentiation in developed economies will continue to support tiered pricing, especially where compliance and traceability demand additional producer investment.
Price and trend analysis aggregate customs statistics, published trade flows, regional chemical park alerts, and customer forecast data. Market intelligence relies on production site audit logs, in-process yield tracking, and real-time raw material quotation feeds. Regulatory review draws on FDA, EFSA, JP, and national health administration bulletins as referenced by production and quality assurance teams.
Year-on-year, the Vitamin B6 supply chain witnessed closure or capacity realignment in select Chinese chemical parks, as site inspection standards forced temporary output suspensions for environmental remediation. Resurgence of feed supplement demand in South Asia drove short-lived raw material shortages, impacting supply tightness for feed and fortified foods. Regional logistics congestion, especially at Pacific Rim ports, introduced irregularity in western contract fulfillment and spot market pricing.
Ongoing inspection rounds by regulatory agencies in China, EU, and the US raised vigilance around genotoxic impurity control and GMP adherence, prompting supply chain actors to realign lot release standards and documentation protocols. Reaction to new or revised heavy metal and solvent impurity standards accelerated process upgrades and promoted secondary QA batch holds at site level.
As a primary producer, key mitigation steps include dynamic sourcing of verified intermediates, diversification beyond mono-source critical raw materials, and strengthening technical exchange with downstream partners. Enhancements to in-process monitoring for yield and impurity profile, adaptation of modular production to manage grade-specific runs, and timely adjustment of packaging or freight as regulatory guidance evolves all contribute to reducing disruption and supporting stable customer supply through regulatory or market turbulence.
Manufacturers supplying Vitamin B6 engage in production for applications ranging from human pharmaceuticals, food fortification, animal nutrition, and personal care to technical and industrial uses. For each sector, user demands and regulatory expectations differ sharply. As production teams, the main concerns stem from both the intended use and the processing demands set by downstream integration.
| Industry | Typical Application | Matching Grade | Key Parameters by Application |
|---|---|---|---|
| Pharmaceutical | Tablets, injections, oral solutions | Pharma Grade / USP / EP | Purity (HPLC/GC basis), trace metal content, microbial limits, particle size (tableting), documented traceability |
| Food & Beverage | Fortification of cereals, drinks, supplements | Food Grade / FCC | Toxicological profile, solvent residues, allergen status, food additive codes, labeling compliance |
| Animal Feed | Premixes, compound feeds | Feed Grade | Bulk purity, absence of harmful by-products, dustiness (handling), flowability, absence of prohibited substances |
| Personal Care | Cosmetics, skin creams, lotions | Cosmetic / Technical Grade | Odor profile, impurity content (aromatic amines, residual organics), color stability in formulations |
| Industrial & Laboratory | Research, intermediate for synthesis | Technical / Laboratory Reagent | Batch consistency, solubility profile, suitability for downstream chemical conversions |
Each industry works with distinct acceptance criteria. Pharma grade batches must conform to compendial monographs such as USP or EP and demand rigorous documentation. Food applications invite separate audit processes, especially focusing on risks related to contaminants regulated in target markets. Feed grade sets a focus on absence of veterinary-prohibited substances and dusting tendency for safe barn handling. Cosmetic applications have separate pigment, odor, and allergen rules. Technical or lab-use material typically sees the widest composition tolerances, with an emphasis on reproducibility and batch reporting.
Purity is always a high attention point, but impurity profiles pull focus in pharmaceutical and food uses due to regulatory and toxicology rules. For animal feed, bulk handling characteristics take priority—low dusting and stable composition win over cosmetic finesse. Color and odor standards vary; higher grades must avoid yellowing and off-notes. Solvent residues become critical in both food and pharma, so solvent selection during processing is usually dictated by final use.
The destination application may dictate everything from traceability requirements to cost tolerance. In production, incoming inquiries must specify sector and use, since compliance reporting and batch release standards diverge right from the outset. Providing examples or performance expectations helps target the accurate grade.
Jurisdiction-specific rules shape both sourcing and processing. Pharmaceutical manufacturing facilities operate under GMP frameworks with certified clean areas; food lines may operate with additional allergen control and HACCP tracking. No single batch can always fit both Pharma and Feed. Customers should refer to their own jurisdiction's code: USP, EP, FCC, GB, or feed/food supplement codes. The production team will align release specification and supporting documents with these demands.
Purity requirements reflect both the intended use and subsequent processing. Pharma preparations demand close control of related substances such as pyridoxal, pyridoxamine, and other degradation products—validated instrumental data are supplied for each lot. Food customers may require tighter residue and heavy metals limits than feed users. Technical grades hold wider tolerance on certain synthetic by-products or microbial limits but must still maintain batch-to-batch reproducibility for downstream application professionals.
Batch capacity and packaging options are aligned with sector requirements. Pharma projects may call for small lots in tamper-evident packaging to protect against cross-contamination, while feed users purchase in tonnage with easy-transfer packaging designs. Single-use laboratory or development batches may not require maximum traceability, but process economics and minimum order size can limit available options. High-purity grades carry higher processing costs due to extra purification and endotoxin control.
Lab-scale testing or pilot plant blending using actual production samples prevents process surprises downstream. Processing conditions can affect performance, such as dissolution rate, compressibility for tablets, or flavor interactions in food. Manufacturers prepare representative batches for customer process evaluation and share release documentation to support customer approval, and adjust process parameters or impurity targets if required by major accounts.
Our Vitamin B6 manufacturing site operates according to internationally recognized quality management frameworks. Audit and certification cycles follow the specific management principles required for pharmaceutical and food ingredient production. Ongoing internal quality reviews, continual personnel training, and integrated deviation management enable robust traceability from raw material intake to final goods release. Most certifications target requirements for food, feed, and pharma-grade supply chains, and updated accreditation is published to approved customers upon request.
For Vitamin B6 dedicated lines, compliance focuses heavily on process validation for batch and continuous operations, particularly for pharma-grade output. Full document trails are maintained for audit by regulatory authorities and contracted clients. Records detail raw material qualification, process water and air monitoring, and all intermediate and final product controls. Each consignment receives certificate documentation covering product batch conformity and key compliance parameters.
Vitamin B6 (Pyridoxine) supplied from our facilities is supported by the required pharmacopoeia and food additive regulatory registrations depending on the designated application. Pharmaceutical and food-grade Pyridoxine comply with current compendial monographs, with testing at release focused on identity, assay, and process-specific purity profile. For feed additive and technical grade, conformity standards are agreed with customers and linked to downstream processing needs or local import regulations. Product-specific certificates—such as Halal, Kosher, GM status, or allergen absence—are provided according to the production campaign, batch history, or inbound raw material status.
Final product certification reflects the relevant grade, process route, and market destination; for example, pharma and food routes are strictly segmented from technical or feed manufacture to control for cross-contamination and specification drift. Full analytical data sets are retained to support post-market traceability claims.
Each produced lot is backed by a full documentation package. The standard package includes: batch-specific Certificates of Analysis based on validated analytical methods, release reports summarizing key in-process control limits, impurity monitoring results, and assurance of conformity to customer requirements. Regulatory support includes access to updated dossiers and compliance statements for regional or application-specific needs.
All analytical data is retained under strict archival requirements, ensuring traceability for multi-year durations as mandated by regulatory codes and auditor guidelines. For custom project batches, technical documentation may be customized through pre-agreed specifications and quality agreements.
Our Vitamin B6 production platforms are engineered for long-term, high-volume capability. Dedicated production lines and buffer inventory management allow consistent supply to customers operating on scheduled or project-based procurement models. Production scheduling flexes to accommodate seasonal or forecasted demand shifts, especially in nutrition, feed, and pharmaceutical sectors where regulatory batch approval cycles may affect short-term offtake.
The cooperative business model adapts contract structures to customer volume, delivery frequency, and application-sensitive specification requirements. For ongoing partnerships, we implement adjustable supply frameworks, including blanket ordering, forward stocking arrangements, or customer-managed safety stock at regional depots as needed.
Production assets are designed for grade-specific Vitamin B6 output, isolating pharma, food, and non-food campaigns with controlled change-over protocols. In-house process control focuses on impurity trending and plant hygiene to minimize batch-to-batch variability, supporting both small-volume and bulk program logistics. Plant reliability is prioritized through dedicated maintenance regimes and preventive bottleneck reviews. Emergency supply planning is reinforced with validated alternate raw material qualification and multi-train production lines, backed by continuous market monitoring of upstream supply conditions.
Sample requests for Vitamin B6 are managed directly by the technical quality and commercial teams. Application review considers the intended end use, grade requirements, and regulatory context to ensure correct sample batch selection. Technical dossiers, safety data, and preliminary analysis reports are provided alongside representative material, and feedback loops are maintained to support reformulation or scale-up trials at customer sites. All samples reflect current process and compliance status, drawn from production that matches the commercial batch specification relevant to the target market.
Procurement collaboration is structured to support routine procurement, spot orders, project-based contracts, or custom-formulation partnerships. Technical exchange may be embedded within the cooperation, allowing for real-time process or quality adjustment in line with customer manufacturing or regulatory changes. Supply plan variations—such as dual-manufacturer programs, rolling forecasts, or joint inventory reviews—are managed through direct dialogue and, where necessary, formalized in blanket agreements or supply protocols.
Customers engaged in long-term contracts benefit from early access to process updates, shared risk management for feedstock volatility, and cooperative alignment of quality improvement initiatives. Direct technical engagement supports application troubleshooting, complaint management, and specification refinement based on shared manufacturing data.
Innovation in Vitamin B6 manufacturing focuses on process intensification and impurity control. Enzyme-catalyzed synthesis routes attract interest due to milder operating conditions and reduced solvent consumption. In reactions involving 2-methyl-3-hydroxy-pyridine, yield optimization depends on catalyst grade and reaction sequence selection. Downstream, the drying and crystallization stages create the most variation across facilities, with crystallization habit influencing filtration efficiency and purity profile.
Formulator interests include improved dispersibility for nutrition premix applications and increased bioavailability for pharmaceutical uses. Industry collaborations, especially in pharmaceutical-grade B6, prioritize polymorphic consistency and particle size distribution. Regional R&D programs in Asia emphasize cost control and waste minimization, while EU-based projects often weigh lifecycle assessments to meet tightening environmental requirements.
Feed and food fortification remain core, but demand for injectable grade B6 grows in clinical nutrition. The cosmetics sector has raised new queries relating to interaction with other micronutrients in topical applications. Recent inquiries focus on compatibility with novel encapsulation systems and stability in energy beverage formulations, showing clear market-driven adaptation in technical service offerings. Manufacturers field increasing requests for allergen and trace contaminant statements, especially from infant nutrition segment buyers.
Removal of process-related impurities—including residual solvents and byproducts—remains an area with the most direct customer impact. Raymond process routes generate certain byproducts that challenge purification systems, and solution lies in continuous monitoring rather than solely endpoint testing. Breakthroughs in in-line analytics now provide earlier warning of off-spec batches. Another key challenge involves moisture control during final packaging; excess moisture creates rapid degradation, thus manufacturers deploy low-humidity rooms and tailor desiccant use by package size and intended distribution region. For some custom grades, micronization leads to static charge buildup complicating dosing accuracy; anti-static handling protocols and surface treatments have addressed this.
The market for Vitamin B6 displays steady annual growth, particularly in fortified beverages, clinical nutrition, and animal feed. Key drivers include ongoing regulatory approval of higher inclusion rates in certain applications and expansion of health supplement formats in Asia-Pacific and Latin America. While pricing shows cyclical swings tied to raw material availability and regulatory shifts, vertical integration strategies buffer sudden cost increases for well-positioned manufacturers. Customer sensitivity to off-taste, compounding behavior, and allergen profiles continues to shape product differentiation and contract terms.
Synthetic route improvements prioritize yield enhancement and energy input reduction. Plants transitioning to closed-loop solvent recovery systems achieve measurable reductions in emissions. In pharmaceutical and food grades, real-time process analytics are redefining batch release criteria—moving towards predictive quality validation rather than lagging lot release testing. Innovators leveraging continuous manufacturing technologies now offer better consistency in granule size and flow properties, noted especially in high-speed packaging lines. Downstream, application-specific grades form a growing percentage of overall output, reflecting a shift from bulk commodity practice to value-added customization.
Green chemistry drives investments in biocatalytic and solventless processing, targeting lower carbon footprints per kg of active. The adoption of renewable-based feedstocks is progressing but remains dependent on cost, regional feedstock supply, and regulatory acceptance. Most new facilities prioritize effluent minimization and solid by-product valorization. Larger buyers already request third-party audits confirming adherence to international environmental management standards. Lifecycle inventory analyses increasingly form an essential part of technical data packages for strategic customers.
Technical teams respond to formulation and process troubleshooting across nutrition, pharma, and specialty applications. Support includes pH compatibility, API-excipient interaction studies, and advice on dissolution profiles for direct compression tablet grades. Formulators with specific granulation or dispersibility concerns benefit from plant-scale trial feedback, drawing from process and production records.
Batch-to-batch particle size or solubility variation requires direct manufacturer insight: teams analyze on-site blending performance and advise on humidity management during high-shear mixing. For feed applications, technical support addresses mixing uniformity in high-moisture pelleting; solutions typically involve collaborative trials and on-demand process adjustments. Application optimization extends to providing pre-screened grades for beverage, powder, and custom-fortified products. Continuous feedback mechanisms with key industrial users feed into ongoing product development priorities.
Every end-user complaint or deviation triggers a full batch traceability investigation; outcomes inform process risk assessments and next production planning cycles. Commitment extends beyond supply: teams guide storage and handling for maximized shelf life, and assist in regulatory documentation during audits. Flexible re-testing and re-certification protocols allow for product revalidation in the event of extended storage or transit delays. Internal quality management systems link customer returns to targeted corrective action, feeding a feedback loop into both routine and new-production scale-up processes.
We operate large-scale synthesis and refining facilities dedicated to Vitamin B6 (Pyridoxine). Our production lines run continuous processes with automated controls, keeping each batch within spec from the raw material feed through to finished product isolation, drying, and milling. This structure reduces batch variability and gives purchasing teams predictable results order after order, regardless of scale. Decades of plant operation and upgrades support consistent throughput, allowing for flexible order volumes without disruption.
Our Vitamin B6 feeds nutrition, feed, and pharmaceutical sectors. In nutrition, it contributes to blends for premixes, fortified foods, and dietary supplements. Animal feed manufacturers incorporate it to meet precise formulation targets in poultry, swine, and aquaculture rations. In pharma, our material serves as an API intermediate and goes toward finished-dose production lines. Supply for each sector remains steady, anchored by strict change controls and audit trails for every production lot.
We control each processing step, from raw ingredient qualification through reactor handling and purity testing, with calibrated analytical equipment on plant premises. No load leaves without passing specification checks for content, residual solvents, and particle profile. Yearly process validations and external audits reinforce reliability, supporting requirements for cGMP, FSSC 22000, and ISO quality programs. Our QC data accompanies each shipment for full transparency and regulatory compliance checks at destination.
Our facility fits packaging rooms for both industrial bulk and precision-packed units. Vitamin B6 ships in fiber drums, multi-wall bags, or lined cartons, directly from the point of production. Packaging teams oversee strict lot traceability, printing, and labelling matched to regulatory and logistics requirements for each sector. Our own logistics team works with buyers to secure timely delivery, whether the order scale involves single loadings or recurring high-volume needs into distribution hubs or manufacturing plants.
Technical advisors on site consult on questions around material performance in feed, food, or pharmaceutical processes. We support troubleshooting for mixing, dispersion, and blending behavior as process conditions demand. Our support team draws from direct experience processing Vitamin B6 at commercial scale, offering practical solutions based on years spent running and qualifying material through international customer audits and in-field evaluations.
Commercial buyers depend on steady and qualified supply when integrating Vitamin B6 into finished goods or distribution portfolios. Direct access to a manufacturing partner with robust capacity helps secure predictable planning without downstream surprises. We keep a stable price structure by managing material sourcing, energy, and labor on site, which enables more efficient cost modeling for buyers. Consolidating procurement with us limits handling steps, shortens lead times, and reduces regulatory risk—especially for operations audited to food, feed, or pharma standards. Our ability to scale, audit, and adapt runs deeper than documentation: it comes from sustained capital commitment and direct production know-how developed in the field.
Running a high-output chemical plant means never losing sight of precision. Our Vitamin B6, known commercially as Pyridoxine Hydrochloride, follows a streamlined, large-scale synthesis pathway under strict GMP conditions. Our supply always features the hydrochloride form because it delivers optimal stability, solubility, and compounding compatibility for a wide range of finished dosage forms. This form has long demonstrated high physical and chemical stability both in storage and during processing, which matters profoundly to our formulation partners.
In tablet, pre-mix, and injectable applications, Pyridoxine Hydrochloride outperforms other B6 species due to robust shelf life. Our product crystallizes as a nearly white to off-white powder, exhibiting minimal odor and extreme purity—measured batch-by-batch in our dedicated QC laboratories.
Assay means more in manufacturing than just a number—it is a strict promise to our customers. Our standard assay specification for Pyridoxine Hydrochloride is not less than 98.0% and not more than 102.0% on an anhydrous basis. Every lot we release undergoes HPLC analysis, backed by full documentation and chromatographic records. These specifications align with major pharmacopoeial monographs, such as current USP and BP. Running a plant means facing constant regulatory scrutiny, so we never lower our assay threshold or compromise on testing rigor.
Operating a vertically integrated process allows us to control raw material input, reaction kinetics, and downstream purification steps. By managing every stage in-house, we keep trace impurities continuously below set ppm limits and ensure the crystalline content of the finished product never dips below guarantee. Each shipment receives a detailed Certificate of Analysis with every batch, showing purity, assay, identification, loss on drying, residue on ignition, and heavy metal screening.
Assay deviations impact tableting, premix stability, and dosing reliability in finished products. Process reliability is not an abstract promise—formulators need consistent active content for robust QA/QC. We understand missed specifications disrupt downstream production and regulatory clearance, so we invest in redundant QC equipment and keep a strong internal training program for lab technicians.
Quality cannot be optionally added at the end of the process; it must drive every raw material check and each critical control point. Our plant upgrades focus on real-time chromatographic checks and inline moisture analysis, which have greatly improved our lot release consistency over the last decade.
Feedback from global partners has helped shape our Pyridoxine Hydrochloride standard. Many customers asked for lower nitrosamine levels and more frequent residual solvent audits, and we delivered on both by installing additional stripping and filtering steps on our main synthesis line. We also maintain readiness for regulatory changes in assay limits or allowed impurities, always prepared with risk assessment and validation studies run on pilot batches before switching to full scale.
Customers seeking additional quality data or non-standard specifications can connect directly with our technical team. We provide detailed batch documentation, impurity profiling, and technical support for new product development. Our process knowledge and plant-scale experience ensure that every kilogram meets international expectations for assay, safety, and reproducibility.
At our facility, we have built our business on clear communication around minimum order quantities and reliable lead times for bulk Vitamin B6, also known as Pyridoxine. These two factors drive production planning, logistics, and our customers’ ability to maintain uninterrupted operations downstream.
For bulk Vitamin B6, the minimum order quantity isn’t arbitrary. It comes out of the realities of scale—how we run our production lines, the batch sizes required for consistent quality, and packaging economics. Our standard packaging typically starts at 25 kg fiber drums, and our MOQs generally begin at the one-drum level. Most industrial inquiries in the food, pharmaceutical, and animal nutrition sectors expect multi-drum shipments, and our production schedule accommodates that scale seamlessly.
This baseline allows us to achieve cost efficiency and reduce changeover downtime. With a single drum ordered, there’s less efficiency than a multi-ton contract, but we still maintain the same quality assurance protocols and batch-traceability measures. Scaling up to pallet-level shipments allows us to deliver not only a competitive price per kilogram but also consistent supply by synchronizing logistics and inventory management at the factory.
Lead time for bulk Vitamin B6 reflects capacity, upstream supply chain reliability, and regulatory compliance steps. Typical lead time stands between two and four weeks after order confirmation. This accounts for both routine production runs and the QA/QC testing phases, which include batch sampling, analysis, and final release by our quality team.
There are periods when demand surges—seasonal trends and sudden market events can accelerate orders from global nutrition or pharmaceutical customers. In those cases, we work closely with buyers' forecasts. Planning ahead helps us secure priority access to raw materials like pyridoxine hydrochloride intermediates, which can be subject to market volatility or logistics bottlenecks. For larger volume contracts with scheduled call-offs, the lead time shrinks because we can allocate production slots well in advance and keep semi-finished stock ready for finishing to order.
Packing and documentation also contribute to lead time. Regulatory documentation such as certificates of analysis, MSDS, and export permits are generated for every batch leaving our facility. We factor these steps into our overall delivery time. Air freight can shorten the window for urgent shipments, but our main supply chain runs on sea freight for cost-effectiveness, particularly for multi-ton orders.
With years operating as a direct manufacturer, we know critical details such as MOQ and lead time go beyond a one-size-fits-all response. Every contract is matched to the customer’s forecast, storage capability, and product formulation plans. Our account managers work alongside production and logistics teams to prevent surprises or delays. We communicate transparently about upcoming shutdowns for routine plant maintenance or upcoming high-volume commitments for long-term customers.
Being direct in our approach lets customers lock in volume, timing, and compliance with full visibility into our manufacturing workflow. By controlling every step from raw material procurement through final release, we reduce risk throughout the supply chain and deliver what our customers need, when they need it.
Direct manufacturing of vitamin B6, also called pyridoxine, faces strict reviews from every side—international food safety agencies, pharmaceutical authorities, and environmental regulators included. Our operations have always prioritized full alignment with these evolving demands. Starting at raw material sourcing, all ingredients entering our production lines must already fit established purity and traceability standards.
Regulatory benchmarks such as USP, EP, and FCC provide clarity for quality and purity in the industry. Our technical team has walked through the validation process for each requirement, running tests to confirm absence of contaminants and tracking impurities down to lower detection limits. During every batch’s synthesis, in-process controls verify each stage before advancing to the next. We operate under GMP and HACCP frameworks, which are audited by independent authorities on a recurring schedule. These systems leave few gaps for deviation or substandard output.
Every batch ships with a Certificate of Analysis (COA) covering appearance, purity, assay, loss on drying, and heavy metals. Our COA reflects actual analytical measurements for that lot, not generic data or past averages. The COA is signed by our in-house quality assurance team on the day of release. We provide a full Material Safety Data Sheet (MSDS) that outlines safe handling, fire and reactivity profiles, storage precautions, and exposure guidelines, all structured according to GHS conventions. This supports safe use through distribution and end-user handling, including compliance with local labor and environmental laws.
Import and export compliance calls for detailed technical dossiers in many markets. On request, we issue origin and phytosanitary certificates, as well as supporting test reports in multiple languages to ensure smooth customs clearance. Our export experience covers all major regions, each with their own documentation quirks, such as the CFDA for China or the ANVISA demands in Brazil. For every order, we track and file shipment-specific certificates for traceability and recall readiness. No shipment proceeds without matching the relevant regulatory envelope for that customer’s destination.
Regulatory shifts never slow down—changes in maximum contaminant levels, labeling rules, and permitted solvents have all impacted this sector. We devote resources to keeping our compliance documentation up-to-date, with full traceability for every lot. Any changes are tracked in revision histories and communicated proactively to clients. When cross-border regulations diverge, our technical group works directly with client quality teams to clarify requirements or produce supplementary documents. Certification for halal, kosher, allergen control, and non-GMO status remains available through our regular third-party audits, with full supporting paperwork upon request.
Real compliance in food and pharmaceutical manufacturing does not stop at internal controls; it extends to open record-keeping and the willingness to show those records to reviewers anywhere in the world. Every document we supply reflects the specific conditions, test results, and storage history for your order. Customers and regulatory inspectors have visited our plant and audited these records first-hand. Direct-from-factory technical transparency remains central to reliable supply.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales3@ascent-chem.com, +8615365186327 or WhatsApp: +8615365186327
